Safety and Efficacy of Denosumab vs Risedronate in Patients With Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis
Adachi J, et al.
Amgen Data Presentations
Below is a selection of Amgen data presentations at ACR 2021. For information on other Amgen data presentations at ACR 2021, please contact Medical Information.
Differences in Patient-Reported Outcomes Between Those Who Stay in Remission and Those Who Exit Remission and Those Who Have Disease-Worsening Following Therapy Withdrawal in Patients With Rheumatoid Arthritis
Bykerk V, et al.
Low Patient Global Assessment of Disease Activity and Negative Rheumatoid Factor Are Strongly Associated With Likelihood of Maintaining Remission Following Tapering of Therapy in Patients With Rheumatoid Arthritis
Curtis JR, et al.
Clinical Characteristics, Including History of Myocardial Infarction and Stroke, Among US PMO Women Initiating Treatment With Romosozumaband Other Anti-Osteoporosis Therapies
Lin T, et al.
Real-World Efficacy of TNF Inhibitors for Treatment of Psoriatic Arthritis by Disease Domains: 6-Month Findings From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Mease PJ, et al.
Efavaleukin Alfa, a Novel IL-2 Mutein, Selectively Expands Regulatory T Cells in Patients With SLE: Interim Results of a Phase 1b Multiple Ascending Dose Study
Tchao N, et al.